{"subsection_name": "Money & Policy", "pub_date": "2011-10-08T00:00:00Z", "byline": {"original": "By DOUGLAS QUENQUA", "contributor": "", "person": [{"lastname": "QUENQUA", "organization": "", "rank": 1, "role": "reported", "firstname": "Douglas"}]}, "abstract": null, "word_count": "557", "print_page": "14", "news_desk": "National", "snippet": "A United States task force\u2019s recommendation against routine prostate-specific antigen testing for prostate cancer may lead to changes in insurance and practice.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "subject", "is_major": "N", "value": "Tests (Medical)", "rank": "1"}, {"name": "subject", "is_major": "N", "value": "Prostate Specific Antigen", "rank": "2"}, {"name": "subject", "is_major": "N", "value": "Health Insurance and Managed Care", "rank": "3"}, {"name": "subject", "is_major": "N", "value": "Prostate Cancer", "rank": "4"}, {"name": "glocations", "is_major": "N", "value": "United States", "rank": "5"}, {"name": "organizations", "is_major": "N", "value": "United States Preventive Services Task Force", "rank": "6"}], "type_of_material": "News", "lead_paragraph": "A United States task force\u2019s recommendation against routine prostate-specific antigen testing for prostate cancer may lead to changes in insurance and practice.", "web_url": "http://www.nytimes.com/2011/10/08/health/policy/08consumer.html", "section_name": "Health", "headline": {"main": "Insurers Review Whether to Still Pay for Routine Screening", "print_headline": "Insurers Review Whether to Still Pay for Routine Screening"}, "slideshow_credits": null, "_id": "5401e41638f0d841b2f3a396", "document_type": "article"}